Celeste L. Ewig

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida

Poster(s):

• ((A-021)) (A-021) Risk Minimization Strategies for Preventing Prenatal Exposure to Teratogenic Medications: Evaluating the Evidence
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• ((A-279)) (A-279) BOOST-HP DrugScan: Identifying Medications Associated with Pregnancy Loss
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• ((B-233)) (B-233) Trends in Utilization of Chronic Asthma Medications among Publicly Insured Children in the US: 2003 to 2020
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• ((B-260)) (B-260) Development of a Pregnancy Loss Risk Score to Address Potential Confounders for Pregnancy Loss
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• ((C-242)) (C-242) A Broad Scan of Associations between Doxycycline and Congenital Malformations Using a Tree-based Data-mining Approach
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET